Temasek-backed Tychan to start human trials next week for COVID-19 treatment

0
16
Singapore’s Tychan, a biotechnology firm backed by state investor Temasek Holdings, said it will begin human clinical trials next week for a potential monoclonal antibody treatment for COVID-19.

Go to Source
Author: